LAKEWOOD, Colo., Feb. 11 /PRNewswire-FirstCall/ -- Mesa Laboratories,
Inc. (Nasdaq: MLAB) today reported significantly higher sales and earnings
for both its fiscal third quarter and nine months ended December 31, 2007.
-- Third quarter revenue increases 13%
-- Third quarter net income increases 37%
-- Third quarter diluted EPS increases 36%
For the third quarter of fiscal 2008, net sales increased 13 percent to $4,614,000 from $4,095,000 in the same quarter last year. Net income for the quarter increased 37 percent to $1,121,000 or $.34 per diluted share compared to $818,000 or $.25 per diluted share one year ago.
For the first nine months of fiscal 2008, net sales increased 15 percent to $13,768,000 from $11,956,000 in the same period last year. Net income for the first nine months increased 36 percent to $3,415,000 or $1.04 per diluted share compared to $2,520,000 or $.78 per share one year ago.
"The third quarter of fiscal 2008 was another good quarter for Mesa,"
said John J. Sullivan, President and Chief Operating Officer. "We had good
revenue growth and exceptional earnings growth, due largely to our improved
gross margins this year. The third quarter is traditionally a weaker
quarter for Mesa, but this year we had exceptional growth in the quarter
for our DataTrace product line. This was due partially to a very weak Q3
for DataTrace last year and partially to the exceptional performance of our
U.S. sales team. DataTrace, has very good momentum going into the last
quarter of fiscal 2008. While our other two core product lines, Raven and
Medical, experienced relatively little growth in the third quarter, we see
these lines recovering in the last quarter of the year to
|SOURCE Mesa Laboratories, Inc.|
Copyright©2008 PR Newswire.
All rights reserved